Mosaic trisomy 16 at amniocentesis in a pregnancy associated with positive non-invasive prenatal testing for trisomy 16, placental trisomy 16, intrauterine growth restriction, intrauterine fetal death, cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, and prenatal progressive decrease of the aneuploid cell line.

CP, Wu FT, Chen YY, et al. Taiwan J Obstet Gynecol. 2023;62(4):597-601. doi:10.1016/j.tjog.2023.05.008. Open Access: Learn more

Tags: Case Report / Case Series, 2023, Taiwan, RAAs

“Mosaic trisomy 16 at amniocentesis can be associated with positive NIPT for trisomy 16, placental trisomy 16, IUGR [intrauterine growth restriction], IUFD [intrauterine fetal demise], cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes, and prenatal progressive decrease of the aneuploid cell line.”